i-sense, a research collaboration supported by our BRC, has been awarded a further £3.8 million by the Engineering and Physical Sciences Research Council (EPSRC) to continue its groundbreaking work developing early warning sensing systems for infectious diseases.
The first drug targeting the known cause of the fatal brain disorder Huntington’s disease has successfully lowered the level of the harmful huntingtin protein in the nervous system, in a trial led by BRC-supported researchers.
PET/MRI scans could become more pleasant for patients, thanks to two films from UCLH's nuclear medicine department.
A new simple test that helps predict which people with type 2 diabetes will benefit most from weight loss surgery has been developed.
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional tests, according to a study published today in Brain.
People excluded from mainstream society in high-income countries have a tenfold increased risk of early death, according to research published in The Lancet.